PROTEINA
Seoul · Founded 2015
About PROTEINA
Our SPID Platform enables the precise detection and analysis of protein interactions at the single-molecule level, offering unparalleled insights into the molecular mechanisms that drive biological processes. Whether you're in drug discovery, diagnostics, or basic research, SPID will revolutionize your approach to PPI analysis.
Company Facts
- Founded: 2015
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $16.8M
- Funding stage: Late Stage Venture
- Last round: Series C (Jul 2021)
- Website: https://www.proteina.co.kr/
- Phone: 82-2-6959-9492
Industries & Categories
Biotechnology, Health Care, Life Science, Oncology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/proteina-48857 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.